Aflibercept 8 mg Two-Year Results from Pivotal PHOTON Trial in Diabetic Macular Edema…
89% and 84% of patients were maintained on ≥12- and ≥16-week dosing intervals, respectively, throughout the two-year period, while sustaining their vision and anatomic improvements At two…